Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia

被引:38
作者
Ernst, Thomas [1 ,2 ]
Score, Joannah [1 ,2 ]
Deininger, Michael [3 ]
Hidalgo-Curtis, Claire [1 ,2 ]
Lackie, Peter [4 ]
Ershler, William B. [5 ]
Goldman, John M. [6 ]
Cross, Nicholas C. P. [1 ,2 ]
Grand, Francis H. [1 ,2 ]
机构
[1] Univ Southampton, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England
[2] Univ Southampton, Sch Med, Div Human Genet, Southampton, Hants, England
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Southampton, Sch Med, Div Infect Inflammat & Immun, Southampton, Hants, England
[5] Harbor Hosp, Hematol Immunol Unit, Baltimore, MD USA
[6] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England
关键词
ABL1; FOXP1; SNX2; ALL; acute lymphoblastic leukaemia; TRANSCRIPT;
D O I
10.1111/j.1365-2141.2010.08457.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>We have identified two novel ABL1 fusion genes in two patients with B-cell acute lymphoblastic leukaemia (ALL) associated with a t(3;9)(p12;q34) and a t(5;9)(q23;q34), respectively. Molecular analysis revealed a FOXP1-ABL1 fusion for the t(3;9) and a SNX2-ABL1 fusion for the t(5;9). The fusions were confirmed by specific amplification of the genomic breakpoints using reverse transcription polymerase chain reaction. The identification of ALL with rare ABL1 fusion partners is important because the leukaemia may respond to tyrosine kinase inhibitors in the same way as ALL patients with a classical BCR-ABL1 fusion gene.
引用
收藏
页码:43 / 46
页数:4
相关论文
共 12 条
[1]   Same mutation, different allele [J].
Aichberger, Karl J. ;
Fleischman, Angela G. ;
Deininger, Michael W. .
BLOOD, 2009, 114 (14) :2853-2854
[2]   Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia [J].
Apperley, Jane F. .
LANCET ONCOLOGY, 2007, 8 (11) :1018-1029
[3]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[4]   Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases [J].
Chase, Andrew ;
Cross, Nicholas C. P. .
CLINICAL SCIENCE, 2006, 111 (04) :233-249
[5]   Endosomal sorting and signalling: an emerging role for sorting nexins [J].
Cullen, Peter J. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (07) :574-582
[6]   Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia [J].
Deenik, W. ;
Beverloo, H. B. ;
van der Poel-van de Luytgaarde, S. C. P. A. M. ;
Wattel, M. M. ;
van Esser, J. W. J. ;
Valk, P. J. M. ;
Cornelissen, J. J. .
LEUKEMIA, 2009, 23 (03) :627-629
[7]   Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].
Druker, BJ ;
Talpaz, M ;
Resta, DJ ;
Peng, B ;
Buchdunger, E ;
Ford, JM ;
Lydon, NB ;
Kantarjian, H ;
Capdeville, R ;
Ohno-Jones, S ;
Sawyers, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037
[8]   Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97 [J].
Escherich, G. ;
Horstmann, M. A. ;
Zimmermann, M. ;
Janka-Schaub, G. E. .
LEUKEMIA, 2010, 24 (02) :298-308
[9]   The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1 [J].
Hidalgo-Curtis, Claire ;
Chase, Andrew ;
Drachenberg, Milton ;
Roberts, Mark W. ;
Finkelstein, Jerry Z. ;
Mould, Sarah ;
Oscier, David ;
Cross, Nicholas C. P. ;
Grand, Francis H. .
GENES CHROMOSOMES & CANCER, 2008, 47 (05) :379-385
[10]   A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34) [J].
Mustjoki, Satu ;
Hernesmenn, Sari ;
Ranhala, Anvo ;
Kahkonen, Marketta ;
Almqvist, Anders ;
Lundan, Tuija ;
Porkka, Kimmo .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (10) :1469-1471